Putative SET-domain methyltransferases in Cryptosporidium parvum and histone methylation during infection

Virulence. 2022 Dec;13(1):1632-1650. doi: 10.1080/21505594.2022.2123363.

Abstract

Cryptosporidium parvum is a leading cause of diarrhoeal illness worldwide being a significant threat to young children and immunocompromised patients, but the pathogenesis caused by this parasite remains poorly understood. C. parvum was recently linked with oncogenesis. Notably, the mechanisms of gene expression regulation are unexplored in Cryptosporidium and little is known about how the parasite impact host genome regulation. Here, we investigated potential histone lysine methylation, a dynamic epigenetic modification, during the life cycle of the parasite. We identified SET-domain containing proteins, putative lysine methyltransferases (KMTs), in the C. parvum genome and classified them phylogenetically into distinct subfamilies (namely CpSET1, CpSET2, CpSET8, CpKMTox and CpAKMT). Our structural analysis further characterized CpSET1, CpSET2 and CpSET8 as histone lysine methyltransferases (HKMTs). The expression of the CpSET genes varies considerably during the parasite life cycle and specific methyl-lysine antibodies showed dynamic changes in parasite histone methylation during development (CpSET1:H3K4; CpSET2:H3K36; CpSET8:H4K20). We investigated the impact of C. parvum infection on the host histone lysine methylation. Remarkably, parasite infection led to a considerable decrease in host H3K36me3 and H3K27me3 levels, highlighting the potential of the parasite to exploit the host epigenetic regulation to its advantage. This is the first study to describe epigenetic mechanisms occurring throughout the parasite life cycle and during the host-parasite interaction. A better understanding of histone methylation in both parasite and host genomes may highlight novel infection control strategies.

Keywords: C. parvum-induced colon cancer; Cryptosporidium; epigenetic mechanisms; histone lysine methyltransferases; histone methylation; life cycle.

MeSH terms

  • Child, Preschool
  • Cryptosporidiosis*
  • Cryptosporidium parvum* / genetics
  • Cryptosporidium parvum* / metabolism
  • Cryptosporidium*
  • Epigenesis, Genetic
  • Histone-Lysine N-Methyltransferase / genetics
  • Histone-Lysine N-Methyltransferase / metabolism
  • Histones / genetics
  • Humans
  • Lysine / genetics
  • Lysine / metabolism
  • Methylation

Substances

  • Histones
  • Histone-Lysine N-Methyltransferase
  • Lysine

Grants and funding

This study was supported by the Plan Cancer “Epigénétique et cancer” 2015 (PARA-CAN #PARA-15-RCA), the Centre National de la Recherche Scientifique, the Institut National de la Santé et de la Recherche Médicale, the Pasteur Institute of Lille, the University of Lille and the Centre Hospitalier Regional Universitaire (CHRU) de Lille. M.S. was supported by a PhD fellowship from the University of Lille. R.W. is a Research Associate with the Belgian National Funds for Scientific Research (FRS-FNRS). The Weitzman lab is supported by the French National Research Agency (ANR PATHO-METHYLOME #ANR-15-CE12-0020), the EUR G.E.N.E. (#ANR-17-EURE-0013), and the “Who Am I?” Laboratory of Excellence #ANR-11-LABX-0071 funded by the French Government through its “Investments for the Future” program operated by the ANR under grant #ANR-11-IDEX-0005-01.